Jorjum Pharma Shares Near Resistance
Magemom Pharma's stock shows positive technical indicators after rebounding from its lowest levels in 2026. It successfully broke through the 9-day exponential moving average (EMA 9) at the 124 riyal level, which enhances the likelihood of resuming the upward trend. Investors are eyeing a key resistance level at 125 riyals, and if this is surpassed, the stock is expected to target higher price levels at 128.50 riyals and 131.05 riyals, reaching a distant target of 137.05 riyals. Meanwhile, technical analysis sets a stop-loss at 120.95 riyals in case the market fails to maintain its gains. Historically, the stock experienced a strong upward wave at the beginning of 2026 before reversing course and declining to a key support level at 121.18 riyals. This level is currently considered an important support zone for a potential positive trend if buying strength increases.
Notice: This Is an AI-Generated Summary
Comments (0)